top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Atai Life Sciences Announces Leadership Transition

May 22, 2024
1 min read

New York and Berlin, May 15, 2024 (Globe Newswire) -- Atai Life Sciences, a clinical-stage biopharmaceutical company, has unveiled its first quarter 2024 financial results and shared corporate updates. Notably, Co-Founder Florian Brand will step down as CEO in a planned transition by the end of 2024. He will be succeeded by Co-Founder and current Chief Scientific Officer, Srinivas Rao, M.D., Ph.D..

Read full article here.

Recent Posts

Create Medicines Raises $122M Series B to Advance In Vivo CAR Therapies

Cambridge, MA, May 14, 2026 (PR Newswire) -- Create Medicines has secured $122 million in Series B financing to accelerate development of its in vivo CAR-based therapeutic programs. The funding will

BD Appoints Peter Menziuso as EVP and President of BD Interventional

Franklin Lakes, NJ, May 18, 2026 (BD) -- BD has appointed Peter Menziuso as executive vice president and president of its BD Interventional segment. The leadership change is intended to support the

Quince Announces OrphAI Acquisition and Up to $187M Private Placement to Advance Pulmonary Pipeline

South San Francisco, CA, May 18, 2026 (Globe Newswire) -- Quince Therapeutics has announced the acquisition of OrphAI alongside a private financing arrangement valued at up to $187 million. The tran

Comments

Life Science Headlines

Create Medicines Raises $122M Series B to Advance In Vivo CAR Therapies

BD Appoints Peter Menziuso as EVP and President of BD Interventional

Quince Announces OrphAI Acquisition and Up to $187M Private Placement to Advance Pulmonary Pipeline

LifeScan Appoints Jonathan Salkin as CEO Amid Leadership Transition

Biogen Completes $5.3B Acquisition of Apellis to Expand Rare Disease Portfolio

UCB to Acquire Candid Therapeutics in Immunology Expansion Deal

Coloplast Appoints Gavin Wood as New CEO

ResMed to Acquire Noctrix Health for $340M to Expand into Restless Legs Syndrome

Teleflex Names Jason Weidman as President and CEO

Sun Pharma to Acquire Organon in $3.1B Deal to Expand Global Women’s Health Portfolio

bottom of page